Procore (NYSE: PCOR) director sells 56,122 shares after option exercise

What happened

Procore Technologies, Inc. (NYSE: PCOR) director and chairman of the board Craig F. Courtemanche Jr. sold 56,122 shares on 2026-10-12. The filing shows 55,930 shares sold at $56.19 and 192 shares at $56.73, and it puts the proceeds at about $3.15 million.

Courtemanche exercised stock options for 56,122 shares at $2.42 the same day, and the option line shows an 11/10/2026 expiration date. The Form 4 says the trades were made under a Rule 10b5-1 plan dated December 9, 2025. The filing also lists indirect holdings in family trusts and a spouse.

Key numbers

Metric	Latest	Change	Source
Shares sold	56,122 shares		SEC Form 4
Sale value	about $3.15 million		SEC Form 4
Shares held after sale	908,316 shares		SEC Form 4
Option exercise price	$2.42		SEC Form 4

Read more: Procore Technologies (PCOR) stock analysis and investment case

Why it matters

OptimistFi's case is that Procore is a high-gross-margin construction software platform whose stock works only if adoption keeps rising and losses turn into durable cash and GAAP profitability. This filing is a small insider-liquidity data point, not an operating update, and the preplanned structure keeps the read-through limited.

OptimistFi's calculation puts the 56,122 shares at about 5.8% of Courtemanche's 964,438-share holding before the reported sale, so the trade trims the stake without resetting it. The same-day exercise means the sale came out of shares created in the filing itself, which keeps the transaction closer to a transaction snapshot than a fresh view on Procore.

Courtemanche still held 908,316 shares afterward, so the report leaves a sizable direct position in place even after monetizing part of the stake. The caveat is the filing's own structure, because the sale sits inside a Rule 10b5-1 plan rather than an open-ended discretionary trade.

That is why the trade matters more as an ownership update than as a view on Procore's business.

Browse: stock research on every company OptimistFi covers

What's next

The option used in the exercise had an expiration date of 11/10/2026, and the filing identifies December 9, 2025 as the plan date. More sales under that plan would strengthen the view that this is planned liquidity, while no follow-on trades would keep the Form 4's impact limited to this single sale. Either way, the filing already shows Courtemanche remains a sizable holder with 908,316 shares after the trade.

More from OptimistFi